Correlation Between El Al and Medivie Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both El Al and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining El Al and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between El Al Israel and Medivie Therapeutic, you can compare the effects of market volatilities on El Al and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in El Al with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of El Al and Medivie Therapeutic.

Diversification Opportunities for El Al and Medivie Therapeutic

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ELAL and Medivie is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding El Al Israel and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and El Al is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on El Al Israel are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of El Al i.e., El Al and Medivie Therapeutic go up and down completely randomly.

Pair Corralation between El Al and Medivie Therapeutic

Assuming the 90 days trading horizon El Al Israel is expected to generate 0.74 times more return on investment than Medivie Therapeutic. However, El Al Israel is 1.34 times less risky than Medivie Therapeutic. It trades about 0.12 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.14 per unit of risk. If you would invest  44,320  in El Al Israel on September 3, 2024 and sell it today you would earn a total of  22,680  from holding El Al Israel or generate 51.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

El Al Israel  vs.  Medivie Therapeutic

 Performance 
       Timeline  
El Al Israel 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in El Al Israel are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, El Al sustained solid returns over the last few months and may actually be approaching a breakup point.
Medivie Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medivie Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

El Al and Medivie Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with El Al and Medivie Therapeutic

The main advantage of trading using opposite El Al and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if El Al position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.
The idea behind El Al Israel and Medivie Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk